Abstract
Background
Micronutrient deficiencies represent a common condition after bariatric surgery (BS). The prevalence of these nutritional disorders before BS is still debated. The aim of our study was to retrospectively evaluate the prevalence of micronutrient deficiencies in candidates for BS.
Methods
A prospectively maintained database of our institution was searched to find all patients who underwent surgery between January and December 2021. The following data were collected: age, gender, body mass index (BMI), obesity-associated diseases, and preoperative serum levels of vitamin B12, folate, and vitamin D.
Results
A total of 174 patients were included in our study. Mean age and BMI were 39.2 ± 11.4 years and 44.3 ± 7.1 kg/m2, respectively. One hundred and thirty-nine patients (79.9%) had at least one preoperative micronutrient disorder, with vitamin D deficiency being the most common (116, 66.7%), followed by a deficit of folate (76, 43.7%) and vitamin B12 (10, 5.7%). Forty-seven (27%) individuals had insufficient levels of vitamin D. Comparison of deficiencies between sexes showed that vitamin B12 < 20 ng/ml was significantly more frequent in women (p = 0.03). DLP showed a mild significant effect on folate levels (p = 0.01), while the association of HNT and T2DM had a mild significant effect on vitamin B12 (p = 0.02).
Conclusions
Preoperative micronutrient deficiencies were frequently found in candidates for BS. Approximately 90% of patients had deficient or insufficient serum levels of vitamin D preoperatively. Almost half of the patients had a preoperative deficit of folate, and vitamin B12 deficiency was significantly more frequent in the female population. It is mandatory to screen all patients undergoing BS for vitamin deficiencies before surgery.
Keywords: Bariatric metabolic surgery, Severe obesity, Micronutrient deficiency, Vitamin deficiency
Introduction
The worldwide prevalence of severe obesity is continuously increasing. Currently, a third of the world’s population is considered overweight or obese [1–3].
BS represents the most effective treatment for patients with severe obesity, and it is associated with sustained weight loss, remission of obesity-related diseases, and reduced mortality [4, 5].
Even though severe obesity is often associated with excessive consumption of calories, nutritional deficiencies are rarely found in BS candidates [6, 7]. The most commonly reported are deficiencies of vitamin D, vitamin B12, folate, and iron [8]. Moreover, the restrictive and/or hypoabsorptive mechanisms of BS may induce postoperative de novo deficiency of thiamine, vitamins B12 and D, folate, iron, and copper. However, reports of severe clinical manifestations have been sporadically described [9–14].
The purpose of this study was to determine the prevalence of micronutrient deficiencies in our patients before BS. We anticipated that the prevalence of micronutrient deficiencies to be high in patients with severe obesity as these patients can mistakenly be considered to not have malnutrition.
Methods
This was a cross-sectional study based on a prospectively collected database of a single bariatric center. All patients submitted to BS from January 1 to December 31, 2021, at our institution were included in the present research. All participants signed informed consent.
All candidates of BS underwent preoperative multidisciplinary evaluation and met the American Society of Metabolic and Bariatric Surgery (ASMBS) guidelines.
The following baseline demographic and clinical characteristics were retrieved from our database: age, gender, BMI, sex (M/F), obesity-related diseases, preoperative serum levels of vitamin B12, folate, and vitamin D. All individuals with prior history of bariatric surgery were excluded from the study population.
Definition of Micronutrient Deficiency
Micronutrients deficiencies were defined in accordance with the most recent published guidelines of the ASMBS [15]:
Vitamin B12: < 200 pg/ml deficiency, < 400 pg/ml suboptimal
Folate: < 3.4 ng/ml deficiency
Vitamin D: 20–30 ng/mL insufficiency, < 20 ng/ml deficiency
Statistical Analysis
Statistical analysis was performed using IBM SPSS version 28. Continuous data were expressed as mean values ± standard deviation, while frequencies were reported as percentages. Shapiro–Wilk test was performed to test normality; ANOVA test and chi-square test (or Fisher’s test when appropriate) were respectively used to compare means and percentages. Correlations among variables were measured using the Pearson correlation coefficient, while a general multivariate regression model was used to analyze the effects of preoperative obesity-related diseases (HTN, T2DM, and DLP) on serum levels of vitamins. All p-values were considered significant when < 0.05.
Results
Study Participants
A total of 214 patients underwent BS during the study period. Data were not available for 26 individuals, while 14 were excluded due to the previous BS; thus, 174 patients undergoing BS were eventually included in our analysis.
Eighty-two (46.9%) patients underwent sleeve gastrectomy (SG), while 83 (48%) were submitted to the one anastomosis gastric bypass (OAGB), and 8 (4.6%) to the Roux-en-Y gastric bypass.
One hundred and twenty-seven (73%) patients undergoing BS were women. Mean age and BMI were 39.2 ± 11.4 years and 44.3 ± 7.1 kg/m2, respectively. Baseline anthropometric and nutritional characteristics of the study population are depicted in Table 1; no statistical difference was found between male and female patients.
Table 1.
Medical and anthropometric characteristics of MBS candidates according to sex
| N | Mean ± standard deviation | P-value | ||
|---|---|---|---|---|
|
BMI (kg/m2) |
Female | 127 | 43.8 ± 6.6 | 0.185 |
| Male | 47 | 45.5 ± 8.2 | ||
| Total | 174 | 44.3 ± 7.1 | ||
|
Age (years) |
Female | 127 | 38.9 ± 11.5 | 0.583 |
| Male | 47 | 39.9 ± 11.1 | ||
| Total | 174 | 39.2 ± 11,4 | ||
|
Vit_B12 (pg/ml) |
Female | 127 | 344.8 ± 111.7 | 0.980 |
| Male | 47 | 344.4 ± 96.1 | ||
| Total | 174 | 344.7 ± 107.4 | ||
|
Folate (ng/ml) |
Female | 127 | 4 ± 2.3 | 0.827 |
| Male | 47 | 4.1 ± 2.4 | ||
| Total | 174 | 7.7 ± 34.8 | ||
|
Vit_D (ng/ml) |
Female | 127 | 16.9 ± 8.2 | 0.635 |
| Male | 47 | 17.6 ± 7.7 | ||
| Total | 174 | 17.1 ± 8 | ||
Rates of patients with type 2 diabetes mellitus (TD2M) or dyslipidemia (DLP) were comparable between the sexes, while hypertension (HTN) was statistically more frequent in the male population (Table 2).
Table 2.
Rate of patients suffering from type 2 diabetes mellitus (TD2M), hypertension (HTN), and dyslipidemia (DLP) according to sex
| Sex n (%) |
Total n (%) |
P-value | |||
|---|---|---|---|---|---|
| F | M | ||||
| TD2M | No | 120 (94.5) | 41 (87.2) | 161 (92.5) | 0.1062 |
| Yes | 7 (5.5%) | 6 (12.8) | 12 (7.5%) | ||
| Total | 174 | ||||
| HTN | No | 101 (79.5) | 23 (48.9) | 124 (71.3) | 0.000* |
| Yes | 26 (20.5) | 24 (51.1) | 50 (21.7) | ||
| Total | 174 | ||||
| DLP | No | 120 (94.5) | 41 (87.2) | 161 (92.5) | 0.1062 |
| Yes | 7 (5.5%) | 6 (12.8) | 12 (7.5%) | ||
| Total | 174 | ||||
* = p < 0.05
Micronutrient Status
One hundred and thirty-nine patients (79.9%) had at least one micronutrient disorder, with vitamin D deficiency being the most common (116, 66.7%), followed by a deficit of folate (76, 43.7%) and vitamin B12 (10, 5.7%). Forty-seven (27%) individuals had insufficient serum levels of vitamin D. Comparison of deficiencies between sexes showed that vitamin B12 < 20 ng/ml was significantly more frequent in women (Table 3).
Table 3.
Comparison of vitamins deficiencies between sexes
| Sex | Total | P-value | ||||
|---|---|---|---|---|---|---|
| Female | Male | |||||
| Vit. B12 deficiency | No | N | 117 | 47 | 164 | 0.03* |
| % | 92.1% | 100.0% | 94.3% | |||
| Yes | N | 10 | 0 | 10 | ||
| % | 7.9% | 0.0% | 5.7% | |||
| Total | 127 | 47 | 174 | |||
| Folate deficiency | No | N | 74 | 24 | 98 | 0.25 |
| % | 58.3% | 51.1% | 56.3% | |||
| Yes | N | 53 | 23 | 76 | ||
| % | 41.7% | 48.9% | 43.7% | |||
| Total | 127 | 47 | 174 | |||
| Vit. D deficiency | No | N | 42 | 16 | 58 | 0.52 |
| % | 33.1% | 34.0% | 33.3% | |||
| Yes | N | 85 | 31 | 116 | ||
| % | 66.9% | 66.0% | 66.7% | |||
| Total | 127 | 47 | 174 | |||
boldface means*p < 0.05
A significant correlation between serum levels of folate and vitamin B12 and between age and serum levels of folate was found (Table 4).
Table 4.
Correlation between baseline age, BMI, and serum levels of vitamin D, B12, and folate
| BMI | Vit_B12 | Folate | Vit_D | Age | ||
|---|---|---|---|---|---|---|
| BMI | Pearson’s correlation | 1 | − 0.013 | − 0.098 | − 0.044 | − 0.040 |
| Sign. (two-tailed) | 0.867 | 0.200 | 0.568 | 0.602 | ||
| N | 174 | 174 | 174 | 174 | 174 | |
| Vit_B12 | Pearson’s correlation | − 0.013 | 1 | 0.250 | 0.141 | 0.043 |
| Sign. (two-tailed) | 0.867 | 0.001 | 0.064 | 0.572 | ||
| N | 174 | 174 | 174 | 174 | 174 | |
| Folate | Pearson’s correlation | − 0.098 | 0.250 | 1 | − 0.001 | 0.251 |
| Sign. (two-tailed) | 0.200 | 0.001 | 0.992 | 0.001 | ||
| N | 174 | 174 | 174 | 174 | 174 | |
| Vit_D | Pearson’s correlation | − 0.044 | 0.141 | − 0.001 | 1 | 0.110 |
| Sign. (two-tailed) | 0.568 | 0.064 | 0.992 | 0.149 | ||
| N | 174 | 174 | 174 | 174 | 174 | |
| Age | Pearson’s correlation | − 0.040 | 0.043 | 0.251 | 0.110 | 1 |
| Sign. (two-tailed) | 0.602 | 0.572 | 0.001 | 0.149 | ||
| N | 174 | 174 | 174 | 174 | 174 | |
boldface means p < 0.05
DLP showed a mild significant effect on folate levels, while the association of HNT and T2DM had a mild significant effect on vitamin B12. No other significant effect of preoperative obesity-related diseases on vitamins level was found (Table 5).
Table 5.
General multivariate regression model of the effects of preoperative obesity related diseases (HTN, hypertension; T2DM, type II diabetes mellitus; DLP, dyslipidemia) on serum levels of vitamins
| Between subjects test | ||||||
|---|---|---|---|---|---|---|
| Independent variable | Dependent variable | Quadratic sum | df | Quadratic mean | F | Sig. |
| TD2M | Vit_B12 | 18,792,779 | 1 | 18,792,779 | 1.692 | 0.195 |
| Folate | 0.525 | 1 | 0.525 | 0.100 | 0.752 | |
| Vit_D | 8640 | 1 | 8640 | 0.134 | 0.715 | |
| HTN | Vit_B12 | 1437,016 | 1 | 1437,016 | 0.129 | 0.720 |
| Folate | 1689 | 1 | 1689 | 0.322 | 0.571 | |
| Vit_D | 28,485 | 1 | 28,485 | 0.442 | 0.507 | |
| DLP | Vit_B12 | 2,724,461 | 1 | 2,724,461 | 0.245 | 0.621 |
| Folate | 30,043 | 1 | 30,043 | 5.727 | 0.018* | |
| Vit_D | 73,255 | 1 | 73,255 | 1.136 | 0.288 | |
| TD2M * HTN | Vit_B12 | 53,612,370 | 1 | 53,612,370 | 4.827 | 0.029* |
| Folate | 2459 | 1 | 2459 | 0.469 | 0.495 | |
| Vit_D | 129,913 | 1 | 129,913 | 2.014 | 0.158 | |
| TD2M * DLP | Vit_B12 | 4,326,903 | 1 | 4,326,903 | 0.390 | 0.533 |
| Folate | 6778 | 1 | 6778 | 1.292 | 0.257 | |
| Vit_D | 1807 | 1 | 1807 | 0.028 | 0.867 | |
| HTN * DLP | Vit_B12 | 17,398,947 | 1 | 17,398,947 | 1.566 | 0.212 |
| Folate | 7498 | 1 | 7498 | 1.429 | 0.234 | |
| Vit_D | 31,157 | 1 | 31,157 | 0.483 | 0.488 | |
* = p < 0.05
Discussion
Primary and secondary BS represents the best treatment for patients with severe obesity [16–18]. However, BS has been associated with nutritional deficiencies in several studies in both restrictive and malabsorptive procedures [19]. Paradoxically, when evaluating patients with severe obesity for BS, it is common to encounter nutritional deficiency preoperatively [7, 8, 20].
The reasons for micronutrient deficiency in severe obesity are not fully understood. In a recent review [21], several mechanisms have been proposed, such as overconsumption of foods with high calories but low nutrient densities, diets with a high-fat content associated with lower intake of vitamins, increased storage of vitamin D in adipose tissue in patients with increased body fat, and possible relation to microbiota dysfunction.
Some authors have also correlated malnutrition to low levels of newly discovered hormones like fibroblast growth factor 23 (FGF 23) [22]. Noteworthy, bariatric surgery induces changes in the circulating concentrations of FGFs [23, 24].
Rates of at least one micronutrient deficiency prior to BS are reported to be 80–90%, with vitamin D deficiency being the most commonly reported deficient micronutrient [8, 20, 21]. Similarly, our study showed that vitamin D deficiency was the most commonly deficient micronutrient occurring in 66.7% of the study population. In addition, we showed that 27% of the patients had vitamin D insufficiency. Therefore, approximately 90% of patients had deficient or insufficient serum levels of vitamin D preoperatively. Vitamin D deficiency has been shown to be associated with several pathologic conditions—osteoporosis, muscle atrophy, recurrent falls, as well as cancer, TD2M, and increased respiratory infections [25]. Its impact can cause severe morbidity and, therefore, it is of major importance to treat it accordingly. Moreover, other micronutrient deficiencies can be associated with severe morbidity in patients with severe obesity. Folate deficiency was shown to occur in 43.7% of our cohort. Interestingly, folate deficiency has been linked with the development of cardiovascular diseases, anemia, and birth defects and may cause neuropsychiatric manifestations [26]. Interestingly, it is reported to be associated with higher BMI, higher body fat accumulation, and greater waist circumference [27]. This further supports the importance of treating folate deficiency in patients with severe obesity. Vitamin B12 deficiency was diagnosed in a relatively low prevalence of our cohort (5.7%), it may be associated with several negative consequences if untreated, such as megaloblastic anemia, glossitis, and sub-acute degeneration of the spinal cord [28]. We strongly recommend evaluating levels of both folate and vitamin B12 before initiating treatment in patients with severe obesity, as treatment of folate deficiency may improve the patient’s symptoms and mask an underlying vitamin B12 deficiency. We could not address iron deficiency in our cohort due to lack of data. However, it is important to note that its prevalence may be high in patients with severe obesity as it was shown that severe obesity disrupts iron homeostasis and weight reduction can notably reduce the release of inflammatory cytokines and hepcidin, which increases iron absorption [29].
Micronutrient deficiency prior to BS was shown to be higher in women than in men [30–32], particularly vitamin D and iron deficiency [8]. Vitamin B12 deficiency was shown to occur in 10.6% of women undergoing BS [33]. Interestingly, vitamin D deficiency was reported to be as high as 6% in women of childbearing age despite adequate intake [34], and vitamin B12 deficiency was shown to strongly correlate with overweight and obesity [35]. Among our BS candidates, the deficit of vit. B12 was more frequent in women and occurred in 10 patients (5.7%), all of which were women. However, other published articles did not show a significant difference in micronutrient deficiency levels when comparing women and men [36, 37]. Other baseline characteristics, such as age and obesity-related diseases, did not significantly influence the serum levels of the studied vitamins.
In the last decade, several guidelines have been published regarding preoperative nutritional care for patients undergoing BS [38–40]. However, BS in patients who suffer from preoperative nutritional deficiencies may worsen these disorders and it may also induce de novo deficits [41].
The type of procedure performed may play a critical role in the development of micronutrient deficiency postoperatively. Krzizek et al. [42] have reported RYGB to have significantly higher deficits when compared to SG in 1-year follow-up in levels of hemoglobin (36.7% vs 18.4%), ferritin (32.4% vs 9.3%), vitamin B12 (16.7% vs 4.9%), vitamin D (90.3% vs 49.2%), vitamin A (33.3% vs 9.0%), and selenium (66.7% vs 6.1%). At 3 years of follow-up, the differences persisted for hemoglobin, ferritin, and vitamin D. OAGB has gained popularity in the last decade and is considered one of the most commonly performed metabolic bariatric procedures worldwide [43]. OAGB has been reported to have more nutritional deficiencies when compared to RYGB [44, 45], and in a survey of metabolic bariatric surgeons which aimed to understand the objection to OAGB, malnutrition emerged as one of the major concerns to not performing OAGB [46]. However, in the recently published multi-institutional survey regarding revisional surgery after OAGB by Musella et al. [47], only 0.13% of patients underwent OAGB revision due to excess weight loss and malnutrition. Carbajo et al. reported that 20% of patients require long-term vitamin D supplementation after OAGB, and 2% of OAGB patients requiring long-term vitamin B12 and folate supplementation [48]. A recent article has also demonstrated that postoperative CONUT score and micronutrient deficiency were comparable after RYGB and OAGB [49]. Even if rarely reported, serious nutritional deficiencies may occur also after LSG [50].
Our study has several limitations. It is of retrospective nature, with no comparative group of patients with normal weight, and we did not address all micronutrients. Moreover, differences between pre- and postmenopausal women could not be analyzed. Despite that, we collected the data prospectively, the cohort is relatively large compared to men versus women, and all micronutrient deficiencies were defined according to recent guidelines.
Conclusion
Preoperative micronutrient deficiencies were frequently found in patients undergoing BS. Approximately 90% of patients had serum levels of vitamin D below the normal threshold preoperatively, while vitamin B12 deficiency was significantly more frequent in the female population. Age and obesity-related diseases did not significantly influence the serum level of the studied nutrients. Due to the risk of postoperative worsening of these nutritional disorders, it is mandatory to screen all candidates of BS and treat them accordingly before surgery.
Funding
Open access funding provided by Università degli Studi di Napoli Federico II within the CRUI-CARE Agreement.
Declarations
Ethical Approval
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national health research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent to Participate
Informed consent was obtained from all individuals included in this study.
Conflict of Interest
The authors declare no competing interests.
Footnotes
Key Points
• Approximately 90% of patients had deficient or insufficient serum levels of vitamin D preoperatively.
• Almost half of the patients had a preoperative deficit of folate.
• Vitamin B12 deficiency was significantly more frequent in the female population.
• Age and obesity-related disease did not significantly influence the serum level of the studied nutrients.
• It is mandatory to screen all BS candidates and treat them accordingly before surgery.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metab Clin Exp. 2019;92:6e10. doi: 10.1016/j.metabol.2018.09.005. [DOI] [PubMed] [Google Scholar]
- 2.Catalán V, Avilés-Olmos I, et al. Time to consider the “exposome hypothesis” in the development of the obesity pandemic. Nutrients. 2022;14(8):1597. doi: 10.3390/nu14081597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yárnoz-Esquiroz P, Olazarán L, Aguas-Ayesa M, et al. ‘Obesities’: position statement on a complex disease entity with multifaceted drivers. Eur J Clin Invest. 2022;52(7):e13811. doi: 10.1111/eci.13811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Schauer PR, Bhatt DL, Kirwan JP, STAMPEDE investigators et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–651. doi: 10.1056/NEJMoa1600869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Doumouras AG, Lee Y, Paterson JM, et al. Association between bariatric surgery and major adverse diabetes outcomes in patients with diabetes and obesity. JAMA Netw Open. 2021;4(4):e216820. doi: 10.1001/jamanetworkopen.2021.6820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Antoniewicz A, Kalinowski P, Kotulecka KJ, et al. Nutritional deficiencies in patients after Roux-en-Y gastric bypass and sleeve gastrectomy during 12-month follow-up. Obes Surg. 2019;29:3277e84. doi: 10.1007/s11695-019-03985-3. [DOI] [PubMed] [Google Scholar]
- 7.Frame-Peterson LA, Megill RD, Carobrese S, et al. Nutrient deficiencies are common prior to bariatric surgery. Nutr Clin Pract. 2017;32:463e9. doi: 10.1177/0884533617712701. [DOI] [PubMed] [Google Scholar]
- 8.Ben-Porat T, Weiss R, Sherf-Dagan S, et al. Nutritional deficiencies in patients with severe obesity before bariatric surgery: what should be the focus during the preoperative assessment. J Acad Nutr Diet. 2020;120(5):874–884. doi: 10.1016/j.jand.2019.10.017. [DOI] [PubMed] [Google Scholar]
- 9.Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow up after bariatric surgery: nutritional and drug issues General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab. 2009;35:544e57. doi: 10.1016/S1262-3636(09)73464-0. [DOI] [PubMed] [Google Scholar]
- 10.Kaniel O, Sherf-Dagan S, Szold A, et al. The effects of one anastomosis gastric bypass surgery on the gastrointestinal tract. Nutrients. 2022;14(2):304. doi: 10.3390/nu14020304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Nunes R, Santos-Sousa H, Vieira S, Nogueiro J, Bouça-Machado R, Pereira A, Carneiro S, Costa-Pinho A, Lima-da-Costa E, Preto J, Group CRI. Vitamin B complex deficiency after Roux-en-Y gastric bypass and sleeve gastrectomy-a systematic review and meta-analysis. Obes Surg. 2022;32(3):873–91. 10.1007/s11695-021-05783-2. [DOI] [PubMed]
- 12.Saltzman E, Karl JP. Nutrient deficiencies after gastric bypass surgery. Annu Rev Nutr. 2013;33:183–203. doi: 10.1146/annurev-nutr-071812-161225. [DOI] [PubMed] [Google Scholar]
- 13.Dogan K, Homan J, Aarts EO, et al. Longterm nutritional status in patients following Roux-en-Y gastric bypass surgery. Clin Nutr. 2018;37:612e7. doi: 10.1016/j.clnu.2017.01.022. [DOI] [PubMed] [Google Scholar]
- 14.Kornerup LS, Hvas CL, Abild CB, et al. Early changes in vitamin B12 uptake and biomarker status following Roux-en-Y gastric bypass and sleeve gastrectomy. Clin Nutr. 2019;38:90611. doi: 10.1016/j.clnu.2018.02.007. [DOI] [PubMed] [Google Scholar]
- 15.Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13(5):727–741. doi: 10.1016/j.soard.2016.12.018. [DOI] [PubMed] [Google Scholar]
- 16.Kermansaravi M, DavarpanahJazi AH, ShahabiShahmiri S, et al. Areas of non-consensus around one anastomosis/mini gastric bypass (OAGB/MGB): a narrative review. OBES SURG. 2021;31:2453–2463. doi: 10.1007/s11695-021-05276-2. [DOI] [PubMed] [Google Scholar]
- 17.Kermansaravi M, Shahmiri SS, DavarpanahJazi AH, et al. One anastomosis/mini-gastric bypass (OAGB/MGB) as revisional surgery following primary restrictive bariatric procedures: a systematic review and meta-analysis. OBES SURG. 2021;31:370–383. doi: 10.1007/s11695-020-05079-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Musella M, Vitiello A, Berardi G, et al. Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial. Surg Endosc. 2021;35(12):6777–6785. doi: 10.1007/s00464-020-08182-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lange J, Königsrainer A. Malnutrition as a complication of bariatric surgery - a clear and present danger? Visc Med. 2019;35(5):305–311. doi: 10.1159/000503040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pellegrini M, Rahimi F, Boschetti S, et al. Pre-operative micronutrient deficiencies in patients with severe obesity candidates for bariatric surgery. J Endocrinol Invest. 2021;44:1413–1423. doi: 10.1007/s40618-020-01439-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kobylińska M, Antosik K, Decyk A, et al. Malnutrition in obesity: is it possible? Obes Facts. 2022;15(1):19–25. doi: 10.1159/000519503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Chaudhary R, Manocha R, Arora A. Correlation of fibroblast growth factor 23 and malnutrition in chronic kidney disease patients on maintenance hemodialysis. J Assoc Physicians India. 2022;70(4):11–12. [Google Scholar]
- 23.Gómez-Ambrosi J, Gallego-Escuredo JM, Catalán V, et al. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. Clin Nutr. 2017;36(3):861–868. doi: 10.1016/j.clnu.2016.04.027. [DOI] [PubMed] [Google Scholar]
- 24.Alvarez-Sola G, Uriarte I, Latasa MU, et al. Bile acids, FGF15/19 and liver regeneration: from mechanisms to clinical applications. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4):1326–1334. doi: 10.1016/j.bbadis.2017.06.025. [DOI] [PubMed] [Google Scholar]
- 25.Musella M, Berardi G, Vitiello A, et al. Vitamin D deficiency in patients with morbid obesity before and after metabolic bariatric surgery. Nutrients. 2022;14(16):3319. doi: 10.3390/nu14163319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Khan KM, Jialal I. Folic Acid Deficiency. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2022. https://www.ncbi.nlm.nih.gov/books/NBK535377. [PubMed]
- 27.Mlodzik-Czyzewska MA, Malinowska AM, Chmurzynska A. Low folate intake and serum levels are associated with higher body mass index and abdominal fat accumulation: a case control study. Nutr J. 2020;19:53. doi: 10.1186/s12937-020-00572-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Azzini E, Raguzzini A, Polito A. A brief review on vitamin B12 deficiency looking at some case study reports in adults. Int J Mol Sci. 2021;22(18):9694. doi: 10.3390/ijms22189694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Alshwaiyat NM, Ahmad A, Wan Hassan WMR, et al. Association between obesity and iron deficiency (review) Exp Ther Med. 2021;22(5):1268. doi: 10.3892/etm.2021.10703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Asghari G, Khalaj A, Ghadimi M, et al. Prevalence of micronutrient deficiencies prior to bariatric surgery: Tehran obesity treatment study (TOTS) OBES SURG. 2018;28:2465–2472. doi: 10.1007/s11695-018-3187-y. [DOI] [PubMed] [Google Scholar]
- 31.Lee PC, Ganguly S, Dixon JB, et al. Nutritional deficiencies in severe obesity: a multiethnic Asian cohort. OBES SURG. 2019;29:166–171. doi: 10.1007/s11695-018-3494-3. [DOI] [PubMed] [Google Scholar]
- 32.Al-Mutawa A, Anderson AK, Alsabah S, et al. Nutritional status of bariatric surgery candidates. Nutrients. 2018;10(1):67. doi: 10.3390/nu10010067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sánchez A, Rojas P, Basfi-Fer K, et al. Micronutrient deficiencies in morbidly obese women prior to bariatric surgery. Obes Surg. 2016;26(2):361–368. doi: 10.1007/s11695-015-1773-9. [DOI] [PubMed] [Google Scholar]
- 34.Al-Musharaf S, McTernan PG, Hussain SD, et al. Prevalence and indicators of vitamin B12 insufficiency among young women of childbearing age. Int J Environ Res Public Health. 2020;18(1):1. doi: 10.3390/ijerph18010001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Baltaci D, Kutlucan A, Turker Y, et al. Association of vitamin B12 with obesity, overweight, insulin resistance and metabolic syndrome, and body fat composition; primary care-based study. Med Glas (Zenica) 2013;10(2):203–210. [PubMed] [Google Scholar]
- 36.Tan BC, Park YS, Won Y, et al. Preoperative nutritional deficiencies in bariatric surgery candidates in Korea. Obes Surg. 2021;31(6):2660–2668. doi: 10.1007/s11695-021-05318-9. [DOI] [PubMed] [Google Scholar]
- 37.Schweiger C, Weiss R, Berry E, et al. Nutritional deficiencies in bariatric surgery candidates. Obes Surg. 2010;20(2):193–197. doi: 10.1007/s11695-009-0008-3. [DOI] [PubMed] [Google Scholar]
- 38.O'Kane M, Parretti HM, Pinkney J, et al. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020;21(11):e13087. doi: 10.1111/obr.13087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists - executive summary. Endocr Pract. 2019;25(12):1346–1359. doi: 10.4158/GL-2019-0406. [DOI] [PubMed] [Google Scholar]
- 40.Sherf Dagan S, Goldenshluger A, Globus I, et al. Nutritional recommendations for adult bariatric surgery patients: clinical practice. Adv Nutr. 2017;8(2):382–394. doi: 10.3945/an.116.014258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.van Rutte PW, Aarts EO, Smulders JF, et al. Nutrient deficiencies before and after sleeve gastrectomy. Obes Surg. 2014;24(10):1639–1646. doi: 10.1007/s11695-014-1225-y. [DOI] [PubMed] [Google Scholar]
- 42.Krzizek EC, Brix JM, Stöckl A, Parzer V, Ludvik B. Prevalence of micronutrient deficiency after bariatric surgery. Obes Facts. 2021;14(2):197–204. doi: 10.1159/000514847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Angrisani L, Santonicola A, Iovino P, et al. Erratum to: bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2290–2292. doi: 10.1007/s11695-017-2773-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Bhandari M, Nautiyal HK, Kosta S, et al. Comparison of one-anastomosis gastric bypass and Roux-en-Y gastric bypass for treatment of obesity: a 5-year study. Surg Obes Relat Dis. 2019;15(12):2038–2044. doi: 10.1016/j.soard.2019.05.025. [DOI] [PubMed] [Google Scholar]
- 45.Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8(3):159–169. doi: 10.1111/cob.12246. [DOI] [PubMed] [Google Scholar]
- 46.Mahawar KK, Borg CM, Kular KS, et al. Understanding objections to one anastomosis (mini) gastric bypass: a survey of 417 surgeons not performing this procedure. Obes Surg. 2017;27(9):2222–2228. doi: 10.1007/s11695-017-2663-0. [DOI] [PubMed] [Google Scholar]
- 47.Musella M, Vitiello A, Susa A, et al. Revisional surgery after one anastomosis/minigastric bypass: an Italian multi-institutional survey. Obes Surg. 2022;32(2):256–265. doi: 10.1007/s11695-021-05779-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Carbajo MA, et al. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obesity surgery. 2017;27(5):1153–1167. doi: 10.1007/s11695-016-2428-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Voglino C, Tirone A, Ciuoli C, et al. Controlling nutritional status (CONUT) score and micronutrient deficiency in bariatric patients: midterm outcomes of Roux-en-Y gastric bypass versus one anastomosis gastric bypass/mini gastric bypass. Obes Surg. 2021;31(8):3715–3726. doi: 10.1007/s11695-021-05486-8. [DOI] [PubMed] [Google Scholar]
- 50.Milone M, Di Minno MN, Lupoli R, et al. Wernicke encephalopathy in subjects undergoing restrictive weight loss surgery: a systematic review of literature data. Eur Eat Disord Rev. 2014;22(4):223–229. doi: 10.1002/erv.2292. [DOI] [PubMed] [Google Scholar]